Aethlon Medical Inc
AEMD2.490USD
-0.170-6.39%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
189.57KMarket Cap
LossP/E TTM
More Details of Aethlon Medical Inc Company
Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Aethlon Medical Inc Info
Ticker SymbolAEMD
Company nameAethlon Medical Inc
IPO dateMar 09, 1994
CEOFrakes (James B)
Number of employees9
Security typeOrdinary Share
Fiscal year-endMar 09
Address11555 Sorrento Valley Road, Suite 203
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone16199410360
Websitehttps://www.aethlonmedical.com/
Ticker SymbolAEMD
IPO dateMar 09, 1994
CEOFrakes (James B)
Company Executives of Aethlon Medical Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Angela Rossetti
Ms. Angela Rossetti
Independent Director
Independent Director
621.00
-74.20%
Mr. Edward G. Broenniman
Mr. Edward G. Broenniman
Independent Chairman of the Board
Independent Chairman of the Board
311.00
-22.25%
Mr. Nicolas Gikakis
Mr. Nicolas Gikakis
Independent Director
Independent Director
178.00
-91.83%
Dr. Chetan S. Shah, M.D.
Dr. Chetan S. Shah, M.D.
Independent Director
Independent Director
34.00
-84.04%
Mr. James B. (Jim) Frakes
Mr. James B. (Jim) Frakes
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
3.00
--
Mr. Steven P. Larosa, M.D.
Mr. Steven P. Larosa, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Susan Noonan
Ms. Susan Noonan
Managing Partner, Investor Relations
Managing Partner, Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Angela Rossetti
Ms. Angela Rossetti
Independent Director
Independent Director
621.00
-74.20%
Mr. Edward G. Broenniman
Mr. Edward G. Broenniman
Independent Chairman of the Board
Independent Chairman of the Board
311.00
-22.25%
Mr. Nicolas Gikakis
Mr. Nicolas Gikakis
Independent Director
Independent Director
178.00
-91.83%
Dr. Chetan S. Shah, M.D.
Dr. Chetan S. Shah, M.D.
Independent Director
Independent Director
34.00
-84.04%
Mr. James B. (Jim) Frakes
Mr. James B. (Jim) Frakes
Chief Executive Officer, Chief Financial Officer, Director
Chief Executive Officer, Chief Financial Officer, Director
3.00
--
Mr. Steven P. Larosa, M.D.
Mr. Steven P. Larosa, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alumni Capital LP
1.66%
Ikarian Capital LLC
1.13%
HRT Financial LP
0.96%
Citadel Advisors LLC
0.70%
Renaissance Technologies LLC
0.34%
Other
95.21%
Shareholders
Shareholders
Proportion
Alumni Capital LP
1.66%
Ikarian Capital LLC
1.13%
HRT Financial LP
0.96%
Citadel Advisors LLC
0.70%
Renaissance Technologies LLC
0.34%
Other
95.21%
Shareholder Types
Shareholders
Proportion
Hedge Fund
2.45%
Corporation
1.82%
Investment Advisor
1.15%
Venture Capital
0.11%
Investment Advisor/Hedge Fund
0.10%
Individual Investor
0.08%
Research Firm
0.02%
Other
94.26%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
39
52.10K
5.57%
--
2025Q3
46
52.10K
55.86%
+11.99K
2025Q2
48
40.11K
17.09%
-2.18K
2025Q1
46
42.29K
10.49%
+21.23K
2024Q4
45
19.95K
3.62%
+14.88K
2024Q3
43
5.07K
1.69%
+2.80K
2024Q2
45
2.27K
0.84%
+1.61K
2024Q1
45
698.00
5.48%
-1.11K
2023Q4
46
700.00
5.72%
-315.00
2023Q3
49
1.01K
111.99%
-18.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Alumni Capital LP
225.56K
3.06%
+225.56K
--
Sep 22, 2025
Ikarian Capital LLC
153.66K
2.08%
-2.00
-0.00%
Jun 30, 2025
Intracoastal Capital, L.L.C.
21.05K
0.29%
+21.05K
--
Sep 10, 2025
Geode Capital Management, L.L.C.
13.47K
0.18%
-2.06K
-13.27%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 16, 2025
Merger
10→1
Jun 05, 2025
Merger
8→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
Date
Type
Ratio
Oct 16, 2025
Merger
10→1
Jun 05, 2025
Merger
8→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
Oct 04, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Aethlon Medical Inc?
The top five shareholders of Aethlon Medical Inc are:
Alumni Capital LP holds 225.56K shares, accounting for 3.06% of the total shares.
Ikarian Capital LLC holds 153.66K shares, accounting for 2.08% of the total shares.
Intracoastal Capital, L.L.C. holds 21.05K shares, accounting for 0.29% of the total shares.
Geode Capital Management, L.L.C. holds 13.47K shares, accounting for 0.18% of the total shares.
Alumni Capital LP holds 225.56K shares, accounting for 3.06% of the total shares.
Ikarian Capital LLC holds 153.66K shares, accounting for 2.08% of the total shares.
Intracoastal Capital, L.L.C. holds 21.05K shares, accounting for 0.29% of the total shares.
Geode Capital Management, L.L.C. holds 13.47K shares, accounting for 0.18% of the total shares.
What are the top three shareholder types of Aethlon Medical Inc?
The top three shareholder types of Aethlon Medical Inc are:
Alumni Capital LP
Ikarian Capital LLC
HRT Financial LP
Alumni Capital LP
Ikarian Capital LLC
HRT Financial LP
How many institutions hold shares of Aethlon Medical Inc (AEMD)?
As of 2025Q4, 39 institutions hold shares of Aethlon Medical Inc, with a combined market value of approximately 52.10K, accounting for 5.57% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -50.30%.
What is the biggest source of revenue for Aethlon Medical Inc?
In --, the -- business generated the highest revenue for Aethlon Medical Inc, amounting to -- and accounting for --% of total revenue.
